Remdesivir, A Potential Drug for COVID-19 Treatment: A New Hope
Keyword(s):
Objective: Coronavirus Diease-2019 (COVID-19) is a pandemic outbreak in the world and is the leading cause of Severe Acute Respiratory Syndrome (SARS). Methods: Currently, many drugs/therapies have been tested for COVID-19 which responded sub optimally to the patients. Remdesivir is a RNA polymerase inhibitor found promising results in ongoing clinical trials and shows faster recovery rate in COVID-19 patients. Currently, USFDA approves for emergent use of this drug in severe COVID-19 patients. Results: In this review, we discussed brief overview of biopharmaceutical and pharmacological aspects of Remdesivir. Moreover, ongoing regulatory status of Remdesivir by official bodies has also been described.
Keyword(s):
2020 ◽
2020 ◽
Vol 8
(4)
◽
pp. 7-12
Keyword(s):
2020 ◽